Furthermore, a high NRF2 expression is related to a poorer overall survival rate in patients with glioma and the activation of the NRF2-Keap1 pathway promotes system xc_ (i.e., NRF2 inhibits ferroptosis; Fan et al., 2017). Here, NFE2L2 is linked to glioma.